OTCMKTS:PXRB - Pixarbio Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.01 0.00 (0.00 %) (As of 03/19/2019 01:39 AM ET)Previous Close$0.01Today's Range$0.01 - $0.0152-Week Range$0.0010 - $1.00Volume2,500 shsAverage VolumeN/AMarket Capitalization$815,000.00P/E RatioN/ADividend YieldN/ABeta-87.3 ProfileDiscussionChartHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. The company researches and develops delivery systems for drugs, devices, or biologics to treat pain, epilepsy, epilepsy, Parkinson's disease, and spinal cord injury. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models. The company is based in Medford, Massachusetts. Receive PXRB News and Ratings via Email Sign-up to receive the latest news and ratings for PXRB and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry N/A Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PXRB Previous Symbol CUSIPN/A CIKN/A Webwww.buddhimatyoga.com Phone617-803-8838Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.97 billion Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares81,500,000Market Cap$815,000.00 Next Earnings DateN/A OptionableNot Optionable Pixarbio (OTCMKTS:PXRB) Frequently Asked Questions What is Pixarbio's stock symbol? Pixarbio trades on the OTCMKTS under the ticker symbol "PXRB." Has Pixarbio been receiving favorable news coverage? Media coverage about PXRB stock has been trending somewhat positive on Monday, according to InfoTrie. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Pixarbio earned a media sentiment score of 1.4 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future. Who are some of Pixarbio's key competitors? Some companies that are related to Pixarbio include Synergy Pharmaceuticals (SGYP), Immune Therapeutics (IMUN), Aeon Global Health (AGHC), Amedica (AMDA), Tenax Therapeutics (TENX), Respirerx Pharmaceuticals (RSPI), Aradigm (ARDM), Manitex Capital (MNX), 3D Signatures (DXD), Healthier Choices Management (HCMC), Protalex (PRTX), Geovax Labs (GOVX), Biocept (BIOC), E-QURE (EQUR) and Anthera Pharmaceuticals (ANTH). What other stocks do shareholders of Pixarbio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pixarbio investors own include Sarepta Therapeutics (SRPT), Community Bank System (CBU), FirstService (FSV), Glencore (GLEN), Invesco S&P 500 Equal Weight Health Care ETF (RYH), United Technologies (UTX), Accelerate Diagnostics (AXDX), Square (SQ), AXA Equitable (EQH) and ICF International (ICFI). Who are Pixarbio's key executives? Pixarbio's management team includes the folowing people: Mr. Francis M. Reynolds, Co-Founder, Chairman, CEO, CFO, Chief Scientific Officer & Corp. Sec. (Age 56)Dr. Jason Criscione, Co-Founder and Chief Technology Officer (Age 37)Dr. Amer Khalil, Co-Founder, MD & Member of Scientific Advisory BoardMr. Haining Dai, Co-Founder & Director of Preclinical NeuroscienceMs. Xi Chen, Co-Founder & Director of Analytical Chemistry How do I buy shares of Pixarbio? Shares of PXRB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Pixarbio's stock price today? One share of PXRB stock can currently be purchased for approximately $0.01. How big of a company is Pixarbio? Pixarbio has a market capitalization of $815,000.00 and generates $1.97 billion in revenue each year. What is Pixarbio's official website? The official website for Pixarbio is http://www.buddhimatyoga.com. How can I contact Pixarbio? Pixarbio's mailing address is 200 BOSTON AVE. STE. 1875, MEDFORD MA, 02155. The company can be reached via phone at 617-803-8838 or via email at [email protected] MarketBeat Community Rating for Pixarbio (OTCMKTS PXRB)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 19 (Vote Outperform)Underperform Votes: 16 (Vote Underperform)Total Votes: 35MarketBeat's community ratings are surveys of what our community members think about Pixarbio and other stocks. Vote "Outperform" if you believe PXRB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PXRB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/19/2019 by MarketBeat.com StaffFeatured Article: What is a Stop Order?